The Effect of a Natural Extract on the Post-prandial Blood Glucose Response After Bread Consumption: a Dose-response of Efficacy

April 30, 2015 updated by: Unilever R&D
This study is designed to identify the minimal effective tested dose of fruit extract consumed with a bread which provides a reduction in venous post-prandial blood glucose compared to a reference bread.

Study Overview

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Charitéplatz 1
      • Berlin, Charitéplatz 1, Germany, 10117
        • Charité Research Organisation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Body mass index (BMI) ≥ 18.0 and ≤ 30.0 kg/m2.
  • Apparently healthy males and females: no medical conditions which might affect the study measurements including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal surgery and inflammatory diseases.
  • Fasting blood glucose value of subjects ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62-110 mg/dl) at screening.

Exclusion criteria:

  • Use of antibiotics within 3 months before day 1; use of any other medication except paracetamol, within 14 days before day 1.
  • Blood donation in the past 3 months and/or during the study.
  • Reported intense sporting activities > 10 h/week.
  • Consumption of > 14 units (female subjects) and > 21 units (male subjects) alcoholic drinks in a typical week.
  • Reported dietary habits: medically prescribed diet, slimming diet, not used to eat 3 meals a day, vegetarian.
  • If female, is pregnant (or has been pregnant during the last < 3 months) or will be planning pregnancy during the study period.
  • If female, is lactating or has been lactating in the 6 weeks before screening and/or during the study period.
  • Dislike, known allergy or intolerance to test products or other food products provided during the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Reference
No added fruit extract
Active Comparator: Active 1
lowest dose of fruit extract
Active Comparator: Active 2
low dose of fruit extract
Active Comparator: Active 3
medium dose of fruit extract
Active Comparator: Active 4
high dose of fruit extract

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Positive incremental post-prandial blood glucose area under the curve
Time Frame: 120 minutes
120 minutes

Secondary Outcome Measures

Outcome Measure
Time Frame
Positive incremental post-prandial blood glucose area under the curve
Time Frame: 180 minutes
180 minutes
Post-prandial insulin response
Time Frame: 120 minutes
120 minutes
Post-prandial insulin response
Time Frame: 180 minutes
180 minutes
AUC of fruit extract calculated by a non-compartmental model
Time Frame: 180 minutes
180 minutes
AUC of fruit extract calculated by a population model
Time Frame: 180 minutes
180 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2015

Primary Completion (Actual)

March 1, 2015

Study Completion (Actual)

March 1, 2015

Study Registration Dates

First Submitted

February 10, 2015

First Submitted That Met QC Criteria

March 13, 2015

First Posted (Estimate)

March 17, 2015

Study Record Updates

Last Update Posted (Estimate)

May 1, 2015

Last Update Submitted That Met QC Criteria

April 30, 2015

Last Verified

April 1, 2015

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • FDS-NAA-1946

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on no added fruit extract

Subscribe